Login / Signup

Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.

Glenn Van HulstJoseph JorssenNathalie JacobsMonique HenketRenaud LouisFlorence SchleichFabrice BureauChristophe J Desmet
Published in: The European respiratory journal (2022)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes